Cargando…
Nanostructural Differentiation and Toxicity of Amyloid-β25-35 Aggregates Ensue from Distinct Secondary Conformation
Amyloid nanostructures are originated from protein misfolding and aberrant aggregation, which is associated with the pathogenesis of many types of degenerative diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and Huntington’s disease. The secondary conformation of peptides is of...
Autores principales: | Song, Yongxiu, Li, Ping, Liu, Lei, Bortolini, Christian, Dong, Mingdong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768673/ https://www.ncbi.nlm.nih.gov/pubmed/29335442 http://dx.doi.org/10.1038/s41598-017-19106-y |
Ejemplares similares
-
Membrane-Modulating Drugs can Affect the Size of Amyloid-β(25–35) Aggregates in Anionic Membranes
por: Khondker, Adree, et al.
Publicado: (2018) -
Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide
por: Friedemann, Merlin, et al.
Publicado: (2015) -
The Effects of Latrepirdine on Amyloid-β Aggregation and Toxicity
por: Porter, Tenielle, et al.
Publicado: (2016) -
Conformational Variability of Amyloid-β and the Morphological Diversity of Its Aggregates †
por: Yagi-Utsumi, Maho, et al.
Publicado: (2022) -
Amyloid β-Sheet Mimics that Antagonize Amyloid Aggregation and Reduce Amyloid Toxicity
por: Cheng, Pin-Nan, et al.
Publicado: (2012)